Cargando…
Identifying Drug Candidates for COVID-19 with Large-Scale Drug Screening
Papain-like protease (PL(pro)) is critical to COVID-19 infection. Therefore, it is a significant target protein for drug development. We virtually screened a 26,193 compound library against the PL(pro) of SARS-CoV-2 and identified several drug candidates with convincing binding affinities. The three...
Autores principales: | Wu, Yifei, Pegan, Scott D., Crich, David, Lou, Lei, Mullininx, Lauren Nicole, Starling, Edward B., Booth, Carson, Chishom, Andrew Edward, Chang, Kuan Y., Xie, Zhong-Ru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002104/ https://www.ncbi.nlm.nih.gov/pubmed/36901828 http://dx.doi.org/10.3390/ijms24054397 |
Ejemplares similares
-
Polyphenols as alternative treatments of COVID-19
por: Wu, Yifei, et al.
Publicado: (2021) -
Polyphenols as Potential Inhibitors of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp)
por: Wu, Yifei, et al.
Publicado: (2021) -
In silico identification of drug candidates against COVID-19
por: Wu, Yifei, et al.
Publicado: (2020) -
ToxDBScan: Large-Scale Similarity Screening of Toxicological Databases for Drug Candidates
por: Römer, Michael, et al.
Publicado: (2014) -
Using Computational Drug-Gene Analysis to Identify Novel Therapeutic Candidates for Retinal Neuroprotection
por: Xie, Edward, et al.
Publicado: (2022)